Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Luminex Corporation LMNX

Luminex Corp develops, manufactures, and sells proprietary biological testing technologies and products to testing laboratories. It primarily serves the life sciences industries by selling products used by laboratory professionals and clinical laboratories in performing diagnostics, drug research and discovery, and clinical tests on patients. Luminex's market segments mainly include Infectious disease, Personalized medicine, and Human genetics. It offers various solutions in diverse markets, inc


NDAQ:LMNX - Post by User

Comment by Moemoney42on Mar 03, 2021 3:49pm
57 Views
Post# 32707532

RE:RE:RE:RE:RE:RE:Strong quarter

RE:RE:RE:RE:RE:RE:Strong quarterMore price exitement today with talk of a take over... quote:

Mar. 03, 2021 3:32 PM ETLuminex Corporation (LMNX)By: Josh FinemanSA News Editor
  • Luminex (NASDAQ:LMNX), a maker of covid-19 testing kits, rose 8.5% after a report that that the company is exploring its options after getting takeover interest.
  • No final decision has been if the company will go ahead with sale or remain a standalone, according to the Bloomberg report.

<< Previous
Bullboard Posts
Next >>